≡ YOU ARE HERE HOME » ABOUT US THIS IS BROAD We seek to better understand the roots of disease and narrow the gap between new biological insights and impact for patients. The Broad Institute of MIT and Harvard is a research organization that convenes a community of researchers from across many disciplines and partner institutions—MIT, Harvard, and Harvard-affiliated hospitals. Based in Cambridge, Massachusetts, the Broad Institute was founded in 2004 to fulfill the promise of genomic medicine—three years after completion of the Human Genome Project, which Broad scientists helped create and lead. Our origins are rooted in genomics, and as biomedical research and knowledge have expanded since 2004, so have we. Our researchers are deeply collaborative, nimbly launching innovative, high-risk projects at every scale, inventing new technologies, building and implementing computational tools, developing new therapeutics to advance into the clinic, mentoring and training the next generation of scientists, and sharing our data and tools openly to enable breakthroughs anywhere. Accelerating biomedical research and improving human health require diversity of all kinds in our community—in education, training, background, perspectives, interests, and identity—because it expands our creativity in how we approach problems and find solutions. Broad aims to ensure that the benefits of genomic medicine are shared by all. We tackle challenges in human health by: Illuminating human disease We use systematic, unbiased approaches to identify the root biological causes of disease and find new opportunities for therapeutic intervention. Reading and editing genomes We generate a whole human genome’s worth of genetic data every few minutes, read gene expression patterns in tissues and in millions of single cells, and use gene editing to create disease models and dissect cell circuitry. Sharing data and tools We make discoveries, data, tools, technologies, and knowledge freely available. We work with industry partners to ensure these innovations benefit patients. Building communities We create, steward, and partner in international collaborations with scientists around the world. We work with researchers and patients to tackle important challenges in biomedicine and find innovative, high-impact solutions. Developing diagnostics and treatments We are revealing deep biological insights into the causes of disease, which are leading to new ways to monitor, diagnose, and treat patients with greater precision. Collaborating, innovating, and empowering We strive to build an inclusive community that empowers and taps into the full potential of every Broadie. ABOUT US This is Broad History Leadership Director Founding Director's Page Partner Institutions and Community Administration Partnering and Licensing #HowWeScience NEWS AT THE BROAD ALL NEWS NEWS / 10.14.21 Next generation prime editing systems move closer to possible therapeutic applications READ MORE NEWS / 10.12.21 René Salazar joins Broad Institute as Chief Equity Officer READ MORE NEWS / 10.28.21 A conversation about the legacy of ENCODE and what comes next READ MORE NEWS / 10.13.21 Mapping the effects of genetic variation, one letter at a time READ MORE CAREERS GIVING NEWS AND MEDIA CONTACT US PRIVACY POLICY Copyright © 2021 Broad Institute. All rights reserved. TWITTER FACEBOOK YOUTUBE INSTAGRAM